HK
Hemant Kantilal Choksey
About Hemant Kantilal Choksey
Data last updated:
Hemant Kantilal Choksey is a Director at Relic Pharma Limited (since 2014). The companies operate in Financial Services. Earlier, Hemant Kantilal Choksey was a Director at Relic Technologies Limited (2006–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Relic Pharma Limited U67120MH1995PLC088000 | Director | 19 Apr 2014 | 1995 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Relic Technologies Limited L46497MH1991PLC064323 | Director | 25 Jan 2006 | 1991 | ₹2.05 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hemant Kantilal Choksey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Baijoo Madhusudan Raval | 00429398 | Relic Pharma Limited | Director |
| Uday Madhusudan Raval | 00727294 | Relic Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemant Kantilal Choksey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemant Kantilal Choksey
Hemant Kantilal Choksey currently holds 1 directorship: Relic Pharma Limited (Director, since 19 Apr 2014).
Hemant Kantilal Choksey was first appointed on 25 Jan 2006 as Director at Relic Technologies Limited. The most recent appointment on record is 19 Apr 2014 at Relic Pharma Limited.
Hemant Kantilal Choksey held 1 earlier board appointment: Relic Technologies Limited (Director, 25 Jan 2006 to 12 Feb 2025).
The current boards of Hemant Kantilal Choksey's companies include Baijoo Madhusudan Raval (Relic Pharma Limited), Uday Madhusudan Raval (Relic Pharma Limited).